Who invested in Auron Therapeutics?
Auron Therapeutics's investors include Qiming Venture Partners, Polaris Partners, DCVC, Eli Lilly and Apollo, and 1 more on record.
United States · Venture startup
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 2 months ago
Funding summaryUpdated 26 Oct 2026
$7.1Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $7.1M sold, first sale Aug 2026
Source recorded
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Auron Therapeutics's investors include Qiming Venture Partners, Polaris Partners, DCVC, Eli Lilly and Apollo, and 1 more on record.
Auron Therapeutics has raised $7.1M across 2 rounds since 2025. One round did not disclose an amount, so the total is a floor.
Auron Therapeutics's most recent round, $7.1M, was in Aug 2026.
Its most recent round, $7.1M in Aug 2026, is also its largest on record.
Auron Therapeutics's first round on record, in Jul 2025, was backed by Qiming Venture Partners, Polaris Partners and DCVC and 3 others.
Auron Therapeutics's latest named round is a Venture, in Jul 2025.
Auron Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.